Nifty Pharma index corrects on profit selling

The Nifty Pharma index fell 1.86% to 7,994.30 on profit booking after rising in past three trading sessions.

The index rose 8.11% in three sessions to 8146 on Thursday (5 March 2020), from a recent closing low of 7535.10 recorded on Monday (2 March 2020).

Meanwhile, the Nifty 50 index fell 289.45 points or 2.57% to 10,979.55.

Among the index constituents, Piramal Enterprises (down 8.85%), Wockhardt (down 6.05%), Glenmark Pharmaceuticals (down 3.93%), Aurobindo Pharma (down 3.26%), Lupin (down 2.24%), Cipla (down 2.05%), Sun Pharmaceutical Industries (down 1.2%) and Dr Reddy's Laboratories (down 0.61%) declined.

Strides Shasun (up 1.55%), Alkem Laboratories (up 0.82%), Cadila Healthcare (up 0.78%), GlaxoSmithKline Pharmaceuticals (up 0.75%), IPCA Laboratories (up 0.65%) and Divi's Laboratories (up 0.55%) advanced.

 

Powered by Capital Market - Live News